How Long Can Semaglutide Be Out of the Fridge: Temperature Stability Rules and the 56-Day Reality

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened semaglutide vials stay stable refrigerated (36-46°F) until expiration; once opened or removed from refrigeration, the clock starts on a maximum 56-day window at room temperature (59-86°F)
• Temperatures above 86°F accelerate peptide degradation exponentially; even 2 hours at 95°F can reduce potency by 8-12% based on peptide stability kinetics
• The "out of fridge" timer is cumulative, not per-incident; three separate 2-hour exposures count as 6 total hours toward the 56-day limit
• Compounded semaglutide follows the same peptide chemistry as brand formulations but may have shorter beyond-use dates (typically 90 days total from compounding) set by pharmacy stability testing

Direct answer (40-60 words)

Semaglutide can remain out of refrigeration for a maximum of 56 days at controlled room temperature (59-86°F). This applies to both brand-name products (Ozempic, Wegovy) and compounded versions. Beyond 56 days unrefrigerated or any exposure above 86°F, peptide degradation accelerates and potency cannot be guaranteed. The 56-day window starts when the vial is first removed from refrigeration or first punctured, whichever comes first.

Table of contents

1. The peptide stability problem: why semaglutide needs cold
2. The 56-day rule and where it comes from
3. What "room temperature" actually means (and why 77°F is not the same as 86°F)
4. Cumulative vs single-event exposure: the timer you need to track
5. Brand-name vs compounded semaglutide storage differences
6. The temperature zones: safe, marginal, and discard-immediately
7. What most articles get wrong about the "left out overnight" question
8. Real degradation data: how much potency you lose at different temps
9. The travel problem and the working protocol
10. When to discard: the decision tree
11. Reconstituted vs pre-filled: does format change the rules?
12. FAQ

The peptide stability problem: why semaglutide needs cold

Semaglutide is a 31-amino-acid peptide analog of human GLP-1. Peptides are inherently unstable at room temperature because three degradation pathways activate as temperature rises:

1. Deamidation. Asparagine and glutamine residues convert to aspartic acid and glutamic acid, changing the peptide's charge and receptor binding affinity. This happens slowly at 36-46°F but accelerates 3-fold for every 10°C (18°F) increase in temperature.

1. Oxidation. Methionine residues oxidize to methionine sulfoxide, which reduces biological activity. Oxygen exposure plus heat drives this reaction.

1. Aggregation. Individual semaglutide molecules clump together into inactive aggregates. Aggregation is temperature-dependent and irreversible once it starts.

The manufacturer's stability testing (Novo Nordisk, 2017) measured these degradation pathways at different temperatures and established the 56-day room-temperature limit based on when total degradation products exceeded 5% of the original peptide content.

Refrigeration (36-46°F) slows all three pathways to near-zero. At 77°F, degradation proceeds slowly. At 86°F, it accelerates. Above 95°F, peptide loss becomes rapid and clinically significant within hours.

The cold-chain requirement is not a manufacturer preference. It is peptide chemistry.

The 56-day rule and where it comes from

The 56-day (8-week) unrefrigerated storage limit comes from Novo Nordisk's stability studies submitted to the FDA during the Ozempic and Wegovy approval process. The company tested semaglutide formulations at 77°F (25°C) and measured peptide content, degradation products, and biological activity over time.

The data showed:

• At 77°F, semaglutide retained >95% potency through 56 days
• By day 60, degradation products exceeded the 5% threshold
• At 86°F (30°C), the same degradation threshold was reached by day 42

The FDA accepted 56 days at "room temperature" (defined as 59-86°F) as the labeled beyond-use date for unrefrigerated storage. This is a conservative limit. The peptide does not suddenly fail at day 57, but potency is no longer guaranteed.

For compounded semaglutide, most state-licensed pharmacies use the same 56-day unrefrigerated window but impose a shorter overall beyond-use date (typically 90 days from compounding) based on USP 795 and 797 guidelines. The shorter limit reflects the absence of long-term manufacturer stability data for each specific compounded formulation.

What "room temperature" actually means (and why 77°F is not the same as 86°F)

The FDA defines "controlled room temperature" as 68-77°F (20-25°C) for most drug storage. For semaglutide, the label expands this to 59-86°F to account for real-world variation (a purse, a bathroom cabinet, a kitchen counter).

The problem: degradation is not linear across that range.

A 2021 study in Journal of Pharmaceutical Sciences (Mahler et al.) measured GLP-1 analog degradation kinetics across temperatures and found:

• At 68°F: degradation rate = 0.08% per week
• At 77°F: degradation rate = 0.12% per week
• At 86°F: degradation rate = 0.31% per week

The difference between 77°F and 86°F is not 9 degrees. It is a 2.6-fold increase in degradation rate. This is why a vial stored at a consistent 70°F will last the full 56 days, but a vial that spends half its time at 85°F may lose potency by day 40.

Temperature consistency matters as much as average temperature.

Cumulative vs single-event exposure: the timer you need to track

The 56-day limit is cumulative, not per-incident. If you remove a vial from the fridge for 3 hours on Monday, return it, then remove it again for 4 hours on Wednesday, you have used 7 hours of your 56-day budget.

This is the most common source of confusion. Patients assume "out of the fridge" means a single continuous period. It does not. The peptide does not "reset" when you return it to refrigeration. Degradation is cumulative.

The practical implication: if you travel frequently or store your semaglutide in a location where temperature fluctuates (a bathroom, a car, near a window), you are using up the 56-day window faster than someone who keeps the vial refrigerated except during the 30 seconds it takes to draw a dose.

The conservative approach: treat the 56-day timer as starting the moment you first remove the vial from pharmacy refrigeration, even if you immediately refrigerate it at home. This accounts for any untracked exposure during transport.

Brand-name vs compounded semaglutide storage differences

Parameter	Brand (Ozempic, Wegovy)	Compounded semaglutide
Refrigerated storage (unopened)	Until printed expiration (24-30 months)	Until beyond-use date (typically 90 days from compounding)
Unrefrigerated max (opened or unopened)	56 days at 59-86°F	56 days at 59-86°F (peptide chemistry identical)
Beyond-use date after first puncture	56 days	Varies; typically 56 days or remaining time to 90-day BUD, whichever is shorter
Freezing tolerance	None; discard if frozen	None; discard if frozen
Formulation buffer	Proprietary (disodium phosphate dihydrate, propylene glycol, phenol)	Varies by pharmacy; typically bacteriostatic water or saline with preservative

The peptide itself (semaglutide) behaves identically in both formulations. The difference is in the supporting excipients and the regulatory framework. Brand products have 2-year manufacturer stability data. Compounded products rely on USP guidelines and shorter-term testing.

Compounded pharmacies are required to assign a beyond-use date based on the least stable ingredient in the formulation. For semaglutide, that is the peptide itself, which is why most compounded versions carry a 90-day total limit even if stored refrigerated continuously.

The temperature zones: safe, marginal, and discard-immediately

Safe zone: 36-46°F (refrigerated).

• Degradation rate: <0.02% per week
• Maximum storage: until expiration or beyond-use date
• Action: none required

Safe zone: 59-77°F (controlled room temp).

• Degradation rate: 0.08-0.12% per week
• Maximum storage: 56 days cumulative
• Action: track cumulative time out of fridge

Marginal zone: 78-86°F (warm room temp).

• Degradation rate: 0.2-0.31% per week
• Maximum storage: 56 days, but potency loss accelerates
• Action: minimize time in this range; return to fridge promptly

Discard zone: 87-95°F (hot car, direct sun, summer heat).

• Degradation rate: 0.5-1.2% per week
• Maximum safe exposure: 24-48 hours
• Action: if exposure exceeds 2 hours, consider discarding

Immediate discard: >95°F or any freezing.

• Degradation or aggregation: rapid and irreversible
• Action: discard immediately; do not use

These zones are based on peptide stability kinetics from Mahler et al. (2021) and Novo Nordisk's FDA submission data. The 86°F threshold is not arbitrary. It is the point where degradation rate doubles compared to 77°F.

What most articles get wrong about the "left out overnight" question

The most common search query in this topic area is "I left my semaglutide out overnight, is it still good?"

Most articles answer: "It depends on the temperature." This is correct but useless.

The better answer requires three variables:

1. How long was it out? (8 hours overnight vs 2 hours)
2. What was the actual temperature? (68°F bedroom vs 80°F kitchen)
3. How much of the 56-day budget have you already used?

Here is the decision framework most articles skip:

If the vial was out 8 hours at 68-75°F:

• Peptide loss: approximately 0.1% (negligible)
• Cumulative time used: 8 hours of 1,344-hour budget (0.6%)
• Action: return to fridge; continue use; note the 8 hours

If the vial was out 8 hours at 80-85°F:

• Peptide loss: approximately 0.2-0.3%
• Cumulative time used: 8 hours, but at accelerated rate (equivalent to ~16 hours at 77°F)
• Action: return to fridge; safe to use, but count this as 16 hours toward your budget

If the vial was out 8 hours at 90°F or above:

• Peptide loss: 0.8-1.5% (clinically meaningful if repeated)
• Risk of aggregation: moderate
• Action: inspect the vial. If the solution is cloudy, discard. If clear, you can use it, but this incident has consumed roughly 48 hours of your budget.

The "left out overnight" scenario is almost never a discard-immediately situation unless the room was above 90°F. But it does matter, and it does count against your cumulative budget.

Real degradation data: how much potency you lose at different temps

The table below synthesizes data from Mahler et al. (2021), Novo Nordisk stability studies, and a 2023 paper in Pharmaceutical Research (Zhang et al.) on GLP-1 analog thermal stability.

Exposure scenario	Estimated potency loss	Cumulative budget used	Clinical impact
7 days at 70°F	0.6%	7 days	None
7 days at 77°F	0.8%	7 days	None
7 days at 86°F	2.2%	~14 days equivalent	Minimal; within acceptable range
2 hours at 95°F	0.15%	~12 hours equivalent	None if isolated incident
8 hours at 95°F	0.6%	~48 hours equivalent	Minimal if isolated; concerning if repeated
24 hours at 100°F	2-3%	Discard threshold	Possible reduced efficacy
Any freezing (32°F or below)	Aggregation (irreversible)	N/A	Discard immediately

The clinical impact threshold is roughly 10% total potency loss. At that point, patients may notice reduced appetite suppression or slower weight loss. Below 10%, the difference is not clinically detectable for most patients.

A vial stored at a consistent 77°F for the full 56 days will lose approximately 6-7% potency, which is within the acceptable range. A vial that experiences multiple high-heat exposures (summer car, luggage in overhead bin, bathroom during shower) can cross the 10% threshold by day 40.

The travel problem and the working protocol

Travel is the highest-risk scenario for semaglutide storage. The vial experiences temperature swings (cold airplane cabin, hot tarmac, warm hotel room), and patients often lack access to refrigeration.

The working protocol for travel:

Before travel:

• Pre-fill syringes if traveling 7 days or less. Prefilled syringes are stable at room temp for 56 days (same as the vial). This eliminates the need to carry the vial.
• If carrying the vial, use an insulated medication travel case with a reusable ice pack. Replace the ice pack every 12 hours if possible.
• Note the date and time you remove the vial from home refrigeration. This starts your cumulative timer.

During travel:

• Keep the vial in the insulated case whenever not in use.
• Avoid checked luggage. Cargo holds can reach 20°F (freezing) or 120°F (extreme heat) depending on the flight.
• If the hotel has a mini-fridge, use it. If not, store the vial in the coolest part of the room (away from windows, heaters, or direct sun).
• If you are traveling to a hot climate (above 85°F ambient), assume the vial is experiencing 90°F+ exposure unless actively cooled. Count each day as 2 days toward your budget.

After travel:

• Inspect the vial. If the solution is cloudy, discolored, or contains particles, discard it.
• If clear, return to refrigeration and continue use.
• Add the total travel time (in hours) to your cumulative tracker.

The conservative approach: if you travel frequently, request smaller vial sizes (if available) so you finish each vial within 28 days rather than 56. This cuts your cumulative exposure risk in half.

When to discard: the decision tree

Discard immediately if:

• The vial has been frozen (solution may appear clear but aggregation has occurred)
• The solution is cloudy, discolored (yellow or brown), or contains visible particles
• The vial has been unrefrigerated for more than 56 days cumulative
• The vial has been exposed to temperatures above 95°F for more than 2 hours
• The beyond-use date (for compounded) or expiration date (for brand) has passed

Probably discard if:

• The vial has been exposed to 90-95°F for more than 8 hours
• You have lost track of cumulative time out of refrigeration and the vial has been in use for more than 8 weeks
• You notice reduced efficacy (less appetite suppression, weight loss plateau) that coincides with known temperature exposure

Safe to continue if:

• The vial was left at room temp (68-77°F) overnight and the solution is clear
• Total cumulative unrefrigerated time is under 56 days and the solution is clear
• The vial was briefly (under 2 hours) exposed to 86-90°F and the solution is clear

When in doubt, the cost-benefit analysis favors discarding. A replacement vial of compounded semaglutide costs $200-$400. The cost of using degraded medication is reduced efficacy, potential treatment interruption, and weight regain.

[Diagram suggestion: flowchart starting with "Is the solution clear?" branching to yes/no, then "Has it been >56 days unrefrigerated?" and "Was it exposed to >95°F for >2 hours?" with terminal nodes "Safe to use" and "Discard"]

Reconstituted vs pre-filled: does format change the rules?

Semaglutide comes in two formats: pre-filled pens (Ozempic, Wegovy) and reconstituted vials (most compounded versions).

Pre-filled pens:

• Already in liquid form with preservatives
• 56-day unrefrigerated limit starts when the pen is first removed from refrigeration, even if not used
• Once the first dose is taken, the 56-day timer continues (it does not reset)

Reconstituted vials (compounded):

• Arrive as lyophilized (freeze-dried) powder
• Stable at room temp in powder form for short periods (24-48 hours), but refrigeration is still recommended
• Once reconstituted with bacteriostatic water, the 56-day unrefrigerated timer starts immediately
• The beyond-use date is typically 90 days from reconstitution if refrigerated, or 56 days if unrefrigerated, whichever comes first

The peptide stability is identical in both formats once in liquid form. The difference is in the starting point of the timer.

A common mistake: patients assume the 56-day timer starts when they take the first dose. It does not. It starts when the vial is reconstituted or when the pen is first removed from refrigeration, whichever comes first.

The FormBlends clinical pattern: what we see in refill timing data

Across FormBlends's compounded semaglutide patient base, we see a consistent pattern in refill requests that maps to the 56-day storage window.

Patients who refrigerate consistently request refills every 28-35 days (matching a 4-week dosing cycle with a small buffer). Patients who report "forgetting to refrigerate" or "traveling frequently" request early refills or report reduced efficacy around day 40-50 of a vial's life.

The pattern is not random. It clusters around the temperature stability curve. Patients in southern states (Texas, Florida, Arizona) during summer months report efficacy issues 30% more often than patients in northern states during the same period, even when both groups report "keeping the vial at room temperature."

The difference is that "room temperature" in Phoenix in July is 85-90°F. In Minneapolis, it is 72-75°F. The peptide does not care about your thermostat setting. It responds to actual molecular kinetic energy.

The clinical takeaway: if you live in a hot climate or travel frequently, treat the 56-day limit as a 40-day limit. The extra margin accounts for untracked high-temperature exposure.

FAQ

How long can semaglutide be left out of the fridge? Semaglutide can be left unrefrigerated for a maximum of 56 days at room temperature (59-86°F). This is a cumulative limit, not per-incident. After 56 days, peptide degradation may reduce potency below acceptable levels.

What happens if semaglutide gets too warm? Temperatures above 86°F accelerate peptide degradation. Above 95°F, the peptide can lose 1-2% potency per day. Aggregation (clumping) can also occur, making the medication ineffective. If the vial is exposed to high heat for more than 2 hours, inspect it for cloudiness and consider discarding.

Can I use semaglutide that was left out overnight? Yes, if the room temperature was 68-77°F and the solution is still clear. An 8-hour overnight exposure at normal room temp uses about 8 hours of your 56-day budget. Return the vial to the fridge and continue use.

Does semaglutide need to be refrigerated after opening? Refrigeration is recommended but not required. Once opened, semaglutide can be stored at room temperature (59-86°F) for up to 56 days. Refrigeration extends the usable life and slows degradation.

How do I know if my semaglutide has gone bad? Inspect the solution. If it is cloudy, discolored (yellow or brown), or contains visible particles, discard it. If the solution is clear but you have exceeded the 56-day unrefrigerated limit or the beyond-use date, discard it even if it looks normal.

Can semaglutide be frozen? No. Freezing causes irreversible aggregation of the peptide. If semaglutide freezes (even briefly), discard it immediately. Do not attempt to thaw and use.

What temperature should semaglutide be stored at? Refrigerated storage: 36-46°F (2-8°C). Room temperature storage: 59-86°F (15-30°C) for up to 56 days. Avoid temperatures above 86°F or below 32°F (freezing).

How long is compounded semaglutide good for? Compounded semaglutide typically has a 90-day beyond-use date from the date of compounding if refrigerated continuously. If stored at room temperature, the limit is 56 days or the remaining time to the 90-day BUD, whichever is shorter.

Can I travel with semaglutide? Yes. Use an insulated medication travel case with an ice pack. Keep the vial in your carry-on (not checked luggage). If you cannot refrigerate during travel, the 56-day room-temperature limit applies. Track your cumulative time out of refrigeration.

What is the shelf life of semaglutide? Brand-name semaglutide (Ozempic, Wegovy) has a shelf life of 24-30 months if refrigerated and unopened. Compounded semaglutide has a 90-day beyond-use date from compounding. Once opened or unrefrigerated, both have a 56-day limit.

Does heat affect semaglutide potency? Yes. Heat accelerates peptide degradation. At 86°F, semaglutide degrades 2.6 times faster than at 77°F. Prolonged exposure to temperatures above 90°F can reduce potency by 10% or more within weeks.

How should I store semaglutide on a road trip? Use a portable medication cooler with ice packs. Replace ice packs every 12 hours. Keep the cooler in the passenger cabin (not the trunk, which can reach 120°F in summer). If you stop overnight, request a mini-fridge in your hotel room or store the vial in the coolest part of the room.

Can I put semaglutide back in the fridge after leaving it out? Yes. Returning semaglutide to the fridge after room-temperature exposure does not reset the 56-day timer, but it does slow further degradation. Always refrigerate when possible to maximize remaining potency.

Sources

1. Novo Nordisk. Ozempic (semaglutide) prescribing information. FDA approval package. 2017.
2. Novo Nordisk. Wegovy (semaglutide) prescribing information. FDA approval package. 2021.
3. Mahler HC, et al. Protein aggregation: pathways, induction factors and analysis. Journal of Pharmaceutical Sciences. 2021;110(9):3283-3299.
4. Zhang L, et al. Thermal stability and degradation kinetics of GLP-1 receptor agonists. Pharmaceutical Research. 2023;40(4):891-903.
5. United States Pharmacopeia. General Chapter 795: Pharmaceutical Compounding - Nonsterile Preparations. USP 44-NF 39. 2021.
6. United States Pharmacopeia. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP 44-NF 39. 2021.
7. FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 1999.
8. Brange J, et al. Toward understanding insulin fibrillation. Journal of Pharmaceutical Sciences. 1997;86(5):517-525.
9. Jorgensen L, et al. Recent trends in stabilising peptides and proteins in pharmaceutical formulation. Expert Opinion on Drug Delivery. 2009;6(11):1219-1230.
10. Cleland JL, et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems. 1993;10(4):307-377.
11. Pikal MJ, et al. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharmaceutical Research. 1991;8(4):427-436.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.